These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 23661402)

  • 1. Stereoselective accumulation of propranolol enantiomers in K562 and K562/ADR cells.
    Zheng XL; Yu QQ; Wang Y; Zeng S
    Chirality; 2013 Jun; 25(6):361-4. PubMed ID: 23661402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study on the interaction between the chiral drug of propranolol and alpha1-acid glycoprotein by fluorescence spectrophotometry.
    Zhang F; Du Y; Ye B; Li P
    J Photochem Photobiol B; 2007 Mar; 86(3):246-51. PubMed ID: 17208004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereoselective transport and uptake of propranolol across human intestinal Caco-2 cell monolayers.
    Wang Y; Cao J; Wang X; Zeng S
    Chirality; 2010 Mar; 22(3):361-8. PubMed ID: 19575464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereoselective disposition of propranolol in rabbits. Role of presystemic organs and dose.
    Marier JF; Pichette V; du Souich P
    Drug Metab Dispos; 1998 Feb; 26(2):164-9. PubMed ID: 9456303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural basis for enantiomer binding and separation of a common beta-blocker: crystal structure of cellobiohydrolase Cel7A with bound (S)-propranolol at 1.9 A resolution.
    Ståhlberg J; Henriksson H; Divne C; Isaksson R; Pettersson G; Johansson G; Jones TA
    J Mol Biol; 2001 Jan; 305(1):79-93. PubMed ID: 11114249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereoselective metabolism of propranolol glucuronidation by human UDP-glucuronosyltransferases 2B7 and 1A9.
    Yu L; Qian M; Liu Y; Yao T; Zeng S
    Chirality; 2010 May; 22(4):456-61. PubMed ID: 19644937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal effects of hyaluronan oligosaccharides on adriamycin resistance of K562/A02 cells.
    Cui X; Zhou S; Xu H; Zhao T; Liu A; Guo X; Wang F
    Anticancer Drugs; 2009 Oct; 20(9):800-6. PubMed ID: 19606017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct determination of S-(-)- and R-(+)-propranolol glucuronide in rat hepatic microsomes by RP-HPLC.
    Yu L; Luan L; Shao Q; Zeng S
    Biomed Chromatogr; 2004 Dec; 18(10):833-7. PubMed ID: 15386572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal effects of droloxifene on multidrug resistance in adriamycin-resistant K562 cell line.
    Li J; Xu LZ; Yao JJ; Guo WJ; Xia P; Chen Y
    Acta Pharmacol Sin; 2001 Nov; 22(11):1023-7. PubMed ID: 11749795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Steady-state pharmacokinetics of propranolol enantiomers in healthy male volunteers.
    Paradiso-Hardy FL; Walker SE; Bowles SK
    Int J Clin Pharmacol Ther; 1998 Jul; 36(7):370-5. PubMed ID: 9707351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential permeation of propranolol enantiomers across human skin in vitro from formulations containing an enantioselective excipient.
    Suedee R; Brain KR; Heard CM
    Chirality; 1999; 11(9):680-3. PubMed ID: 10506427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereoselective increase of plasma concentrations of the enantiomers of propranolol and atenolol during exercise.
    Stoschitzky K; Kahr S; Donnerer J; Schumacher M; Luha O; Maier R; Klein W; Lindner W
    Clin Pharmacol Ther; 1995 May; 57(5):543-51. PubMed ID: 7768077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma protein binding of propranolol enantiomers as a major determinant of their stereoselective tissue distribution in rats.
    Takahashi H; Ogata H; Kanno S; Takeuchi H
    J Pharmacol Exp Ther; 1990 Jan; 252(1):272-8. PubMed ID: 2299595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Development of a K562 multidrug-resistant cell line and study on proteins with altered expression].
    Wang Y; Cao J; Zeng S
    Shi Yan Sheng Wu Xue Bao; 2003 Oct; 36(5):342-6. PubMed ID: 14724945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regio- and stereoselective oxidation of propranolol enantiomers by human CYP2D6, cynomolgus monkey CYP2D17 and marmoset CYP2D19.
    Narimatsu S; Nakata T; Shimizudani T; Nagaoka K; Nakura H; Masuda K; Katsu T; Koeda A; Naito S; Yamano S; Miyata A; Hanioka N
    Chem Biol Interact; 2011 Feb; 189(3):146-52. PubMed ID: 21184751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chiral interactions of the drug propranolol and α1-acid-glycoprotein at a micro liquid-liquid interface.
    Lopes P; Kataky R
    Anal Chem; 2012 Mar; 84(5):2299-304. PubMed ID: 22250754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enantioselective biodegradation of pharmaceuticals, alprenolol and propranolol, by an activated sludge inoculum.
    Ribeiro AR; Afonso CM; Castro PM; Tiritan ME
    Ecotoxicol Environ Saf; 2013 Jan; 87():108-14. PubMed ID: 23131609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a reservoir-type transdermal enantioselective-controlled delivery system for racemic propranolol using a molecularly imprinted polymer composite membrane.
    Suedee R; Bodhibukkana C; Tangthong N; Amnuaikit C; Kaewnopparat S; Srichana T
    J Control Release; 2008 Aug; 129(3):170-8. PubMed ID: 18550193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chiral recognition based on enantioselective interactions of propranolol enantiomers with cyclosophoraoses isolated from Rhizobium meliloti.
    Lee S; Choi Y; Lee S; Jeong K; Jung S
    Chirality; 2004 Mar; 16(3):204-10. PubMed ID: 14770418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enantioselective binding to the human organic cation transporter-1 (hOCT1) determined using an immobilized hOCT1 liquid chromatographic stationary phase.
    Moaddel R; Patel S; Jozwiak K; Yamaguchi R; Ho PC; Wainer IW
    Chirality; 2005 Oct; 17(8):501-6. PubMed ID: 16113995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.